Patents Assigned to Creatics LLC
  • Publication number: 20240041438
    Abstract: Embodiments of the present invention relate to non-invasive methods and compositions for collecting detecting, measuring, and identifying target molecules. In some embodiments, methods and compositions relate to target molecules in gastrointestinal lavage fluid or feces.
    Type: Application
    Filed: December 15, 2022
    Publication date: February 8, 2024
    Applicant: Creatics LLC
    Inventors: Lewis K. Pannell, Jana Rocker, Carlo Contreras, Jack Di Palma
  • Publication number: 20220128563
    Abstract: The present invention relates to non-invasive methods for the diagnosis and prognosis of pancreatic cancer. In some embodiments, such methods and compositions relate to particular pancreatic cancer biomarkers and combinations thereof.
    Type: Application
    Filed: July 20, 2021
    Publication date: April 28, 2022
    Applicant: Creatics LLC
    Inventors: Lewis K. Pannell, Jana Rocker
  • Publication number: 20200400673
    Abstract: Described herein are non-invasive or minimally invasive methods and compositions for collecting and assessing samples for detection of gastrointestinal (GI) tract cancers and pancreatic cancers. Samples comprising gastrointestinal lavage fluid (GLF) are obtained from subjects and screened against a glycan microarray to reveal disease-specific glycan-binding patterns by immunoglobulins contained in the GLF, especially immunoglobulin A (IgA). The disease-specific glycan-binding patterns include a disease-specific glycan or subset of glycans from the microarray that are bound by the immunoglobulins in GLF at highest intensities or at lowest intensities, as well as one or more glycan motifs found within this disease-specific subset of glycans.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Applicant: Creatics LLC
    Inventors: Lewis K. Pannell, Joseph John Otto
  • Publication number: 20190239863
    Abstract: Embodiments of the present invention relate to non-invasive methods and compositions for collecting detecting, measuring, and identifying target molecules. In some embodiments, methods and compositions relate to target molecules in gastrointestinal lavage fluid or feces.
    Type: Application
    Filed: January 10, 2019
    Publication date: August 8, 2019
    Applicant: Creatics LLC
    Inventors: Lewis K. Pannell, Jana Rocker, Carlo Contreras, Jack Di Palma
  • Publication number: 20190234951
    Abstract: The present invention relates to non-invasive methods for the diagnosis and prognosis of pancreatic cancer. In some embodiments, such methods and compositions relate to particular pancreatic cancer biomarkers and combinations thereof.
    Type: Application
    Filed: July 26, 2018
    Publication date: August 1, 2019
    Applicant: Creatics LLC
    Inventors: Lewis K. Pannell, Jana Rocker
  • Patent number: 10226238
    Abstract: Embodiments of the present invention relate to non-invasive methods and compositions for collecting detecting, measuring, and identifying target molecules. In some embodiments, methods and compositions relate to target molecules in gastrointestinal lavage fluid or feces.
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: March 12, 2019
    Assignee: Creatics LLC
    Inventors: Lewis Pannell, Jana Rocker, Carlo Contreras, Jack Di Palma
  • Publication number: 20140343451
    Abstract: Embodiments of the present invention relate to non-invasive methods and compositions for collecting detecting, measuring, and identifying target molecules. In some embodiments, methods and compositions relate to target molecules in gastrointestinal lavage fluid or feces.
    Type: Application
    Filed: September 12, 2011
    Publication date: November 20, 2014
    Applicant: Creatics LLC
    Inventors: Lewis Pannell, Jana Rocker, Carlos Contreras, Jack Di Palma